Design the most effective surveillance strategy to detect antigenic changes in circulating influenza strains that could undermine vaccine effectiveness. Which combination of activities would be best?

Randomly sample household pets for influenza-like viruses and use ecological niche modeling to forecast human vaccine failure, since animal sampling always predicts human antigenic variation with perfect accuracy.

Rely solely on passive clinical reporting of severe cases without laboratory sequencing, because clinical severity alone is a sufficient proxy for antigenic change and simplifies logistics while eliminating unnecessary lab costs.

Integrate global sentinel surveillance with frequent viral genetic sequencing, antigenic characterization (e.g., hemagglutination inhibition assays), real-time sharing of data to vaccine strain selection committees, and epidemiologic monitoring of vaccine breakthrough infections.

Delay surveillance efforts until large epidemics emerge and then retrospectively sequence viruses to determine which old vaccine failed, because retrospective analysis is the quickest and least resource-intensive way to inform future vaccine updates.